Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Eaton Vance Worldwide Health Sciences Fund

+ Add to Watchlist

ETHSX:US

13.44 USD 0.28 2.04%

As of 09:29:30 ET on 04/27/2015.

Snapshot for Eaton Vance Worldwide Health Sciences Fund (ETHSX)

Year To Date: +9.71% 3-Month: +5.49% 3-Year: +27.70% 52-Week Range: 9.92 - 13.84
1-Month: +0.30% 1-Year: +35.89% 5-Year: +20.54% Beta vs SPX: 0.93

Mutual Fund Chart for ETHSX

No chart data available.
  • ETHSX:US 13.44
  • 1M
  • 1Y
Interactive ETHSX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ETHSX

Eaton Vance Worldwide Health Sciences Fund is an open-end fund incorporated in the USA. The Fund's objective is long-term capital growth. The Fund invests at least 80% of its net assets in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care.

Inception Date: 07-26-1985 Telephone: 1-617-482-8260
Managers: SAMUEL DAVID ISALY / SVEN H BORHO
Web Site: www.eatonvance.com

Fundamentals for ETHSX

NAV (on 2015-04-27) 13.44
Assets (M) (on 2015-03-31) 1,772.53
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 0.00

Dividends for ETHSX

Dividend Type Short Term Cap Gain
Dividend Frequency Annual
Last Dividend Net (on 2014-12-16) 0.56
Dividend Yield (ttm) 15.01

Fees & Expenses for ETHSX

Front Load 5.75
Back Load 0.00
Current Mgmt Fee 1.02
Redemption Fee 1.00
12b1 Fee 0.25
Expense Ratio 1.46

Top Fund Holdings for ETHSX

Filing Date: 02/27/2015
Name Position Value % of Total
Regeneron Pharmaceuticals Inc 186,000 76,974,240 4.485%
Novartis AG 664,000 67,910,002 3.957%
HCA Holdings Inc 942,000 67,390,680 3.926%
Bristol-Myers Squibb Co 1,080,000 65,793,600 3.833%
Biogen Inc 156,000 63,896,040 3.723%
Amgen Inc 392,000 61,826,240 3.602%
AbbVie Inc 970,000 58,685,000 3.419%
Actavis plc 195,300 56,902,608 3.315%
Shire PLC 230,000 55,639,300 3.242%
Celgene Corp 430,000 52,257,900 3.045%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil